![](https://menopausesymposium.co.uk/wp-content/uploads/2024/09/CVD.jpg)
Hormone Replacement Therapy and Cardiovascular Disease: Risks and Benefits
Cardiovascular disease (CVD) is the leading cause of mortality and a significant cause of morbidity
The menopause symposium is an online forum aimed to discuss, share, and disseminate new information and scientific findings on different topics related to the diagnosis and management of the menopause.
Join our hosts who bring you new scientific articles and research studies over our live symposium.
You can also check our previous episodes, comment, and engage with our community.
Cardiovascular disease (CVD) is the leading cause of mortality and a significant cause of morbidity
Menopause transition is associated with changes in body composition including an increase in fat mass,
Is there a placebo effect in menopause treatments?
HRT vs COCP for the management of premature ovarian failure
Efficacy of conjugated estrogens/bazedoxifene as hormone replacement therapy in the menopause?
What is the safety and efficacy of testosterone replacement therapy in the menopause?
Join us for an interactive session where we discuss recent evidence from a randomised trial on the use of fezolinetant in women with menopause
If you would like to join upcoming sessions of the symposium live, please sign up to our newsletter and our team will send you future joining instructions.
All the symposium sessions are directly broadcasted on our YouTube Channel. Please subscribe and activate the notification to receive regular updates on new episodes!
Mr Wattar is an Associate Professor of Reproductive Medicine and a Consultant Obstetrician and Gynaecologist and an RCOG accredited Subspecialist in Reproductive Medicine at the Beginnings Assisted Conception Unit at Epsom and St Helier University Hospitals in London.
Mr Wattar has a special interest in Endocrine Gynaecology and leads a dedicate clinic in south London for women with PCOS, ovulatory disorders, menstrual irregularities, and complex menopause health needs.
He leads the several Research Groups at University College London and Anglia Ruskin University which are focused on delivering high quality research to address the health needs of women and their families.
Dr Talaulikar is an Associate Specialist in Reproductive Medicine at University College London Hospitals and an Hon. Associate Professor in Women’s Health at the University College London.
Dr Talaulikar has advanced clinical expertise in the field of reproductive endocrinology, PCOS, ovulation induction, recurrent miscarriage, and menopause.
He run dedicated clinics for women with premature ovarian insufficiency, Turner syndrome, and early menopause.
He published widely on several topics related to Menopause health and is passionate integrating top quality evidence into clinical practice.
The information provided on the Menopause Symposium website is for general informational purposes only. It is not a substitute for professional medical advice. We do not endorse specific treatments, and content may change without notice. By using the site, you agree to these terms.
©Copyright Menopause Symposium